Table 3 Logistic regression stratified by menopause status for relationship between polymorphisms and the risk of female breast cancer in Inuit

CYP1A1 (Ile/Ile vs Ile/Val + Val/Val)

2/17 vs 14/25

5.18

1.01

26.5

0.048

2/15 vs 12/56

1.47

0.28

7.65

0.65

CYP1B1 (leu/Leu vs Leu/Val + Val/Val)

16/28 vs 1/13

0.12

0.013

1.00

0.050

10/52 vs 4/19

1.56

0.40

6.09

0.52

COMT (Val/Val vs Val/Met + Met/Met)

3/8 vs 14/34

1.19

0.27

5.28

0.82

4/11 vs 10/60

0.53

0.13

2.20

0.38

CYP17 (A1/A1 vs A1/A2 + A2/A2)

7/11 vs 9/31

0.42

0.12

1.43

0.16

5/12 vs 9/57

0.47

0.12

1.85

0.28

CYP19 (C > T) (CC vs CT + TT)

13/31 vs 4/11

0.79

0.21

3.04

0.74

10/48 vs 4/24

0.94

0.24

3.60

0.93

CYP19 (TTTA)n (F/F vs F/S + S/S)^#

14/33 vs 3/7

0.95

0.21

4.27

0.94

13/43 vs 1/18

0.21

0.025

1.79

0.15